Short-Term Fever-Range Hyperthermia Accelerates NETosis and Reduces Pro-inflammatory Cytokine Secretion by Human Neutrophils.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 03 06 2019
accepted: 23 09 2019
entrez: 5 11 2019
pubmed: 5 11 2019
medline: 30 10 2020
Statut: epublish

Résumé

Fever is a hallmark of infections and inflammatory diseases, represented by an increase of 1-4°C in core body temperature. Fever-range hyperthermia (FRH) has been shown to increase neutrophil recruitment to local sites of infection. Here, we evaluated the impact of a short period (1 h) of FRH (STFRH) on pro-inflammatory and bactericidal human neutrophil functions. STFRH did not affect neutrophil spontaneous apoptosis but reverted the lipopolysaccharide (LPS)-induced anti-apoptotic effect compared with that under normothermic conditions. Furthermore, STFRH accelerated phorbol myristate acetate (PMA)-induced NETosis evaluated either by the nuclear DNA decondensation at 2 h post-stimulation or by the increase in extracellular DNA that colocalized with myeloperoxidase (MPO) at 4 h post-stimulation. Increased NETosis upon STFRH was associated with an increase in reactive oxygen species (ROS) production but not in autophagy levels. STFRH also increased NETosis in response to

Identifiants

pubmed: 31681277
doi: 10.3389/fimmu.2019.02374
pmc: PMC6813732
doi:

Substances chimiques

CXCL8 protein, human 0
IL1B protein, human 0
Interleukin-1beta 0
Interleukin-8 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2374

Informations de copyright

Copyright © 2019 Keitelman, Sabbione, Shiromizu, Giai, Fuentes, Rosso, Ledo, Miglio Rodriguez, Guzman, Geffner, Galletti, Jancic, Gómez and Trevani.

Références

J Am Soc Nephrol. 2006 May;17(5):1345-53
pubmed: 16597688
Am J Pathol. 2011 Jul;179(1):199-210
pubmed: 21703402
Infect Immun. 2000 Mar;68(3):1265-70
pubmed: 10678936
Infect Immun. 1977 Jun;16(3):947-54
pubmed: 19356
Sci Immunol. 2018 Aug 24;3(26):
pubmed: 30143555
Blood. 2012 Feb 2;119(5):1214-6
pubmed: 22210873
J Infect Dis. 2003 Jun 15;187 Suppl 2:S364-9
pubmed: 12792853
Am J Respir Cell Mol Biol. 2012 Jun;46(6):807-14
pubmed: 22281986
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
PLoS One. 2012;7(2):e32366
pubmed: 22389696
Cell Res. 2011 Feb;21(2):290-304
pubmed: 21060338
Am J Pathol. 2003 Jun;162(6):2005-17
pubmed: 12759256
J Immunol. 2005 Mar 15;174(6):3676-85
pubmed: 15749906
J Biomed Biotechnol. 2011;2011:284759
pubmed: 21541219
Nat Rev Immunol. 2019 Apr;19(4):255-265
pubmed: 30816340
J Immunol. 2008 Aug 15;181(4):2636-43
pubmed: 18684954
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
J Innate Immun. 2017;9(4):387-402
pubmed: 28467984
Infect Immun. 1977 Dec;18(3):673-9
pubmed: 412788
J Innate Immun. 2018;10(5-6):365-372
pubmed: 29874678
Eur J Clin Invest. 2018 Nov;48 Suppl 2:e12952
pubmed: 29772063
PLoS Pathog. 2019 Jun 20;15(6):e1007812
pubmed: 31220187
J Immunol. 2009 Aug 15;183(4):2632-41
pubmed: 19620311
Cell Death Dis. 2016 Oct 27;7(10):e2437
pubmed: 27787523
Blood. 2012 Jun 28;119(26):6335-43
pubmed: 22596262
Nat Med. 2014 May;20(5):511-7
pubmed: 24784231
J Pharmacol Exp Ther. 2013 Jun;345(3):430-7
pubmed: 23536315
J Immunol. 2002 Nov 15;169(10):5396-400
pubmed: 12421912
Annu Rev Immunol. 2012;30:459-89
pubmed: 22224774
Nat Rev Immunol. 2015 Jun;15(6):335-49
pubmed: 25976513
J Cell Biol. 2007 Jan 15;176(2):231-41
pubmed: 17210947
Front Immunol. 2018 Feb 19;9:269
pubmed: 29515581
Trans Am Clin Climatol Assoc. 2011;122:34-47
pubmed: 21686207
Cell Death Differ. 2019 Mar;26(3):395-408
pubmed: 30622307
Sci Immunol. 2018 Aug 24;3(26):
pubmed: 30143554

Auteurs

Irene A Keitelman (IA)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Florencia Sabbione (F)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Carolina M Shiromizu (CM)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Constanza Giai (C)

Instituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM) UBA-CONICET, Buenos Aires, Argentina.

Federico Fuentes (F)

Laboratorio de Microscopía, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

David Rosso (D)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Camila Ledo (C)

Instituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM) UBA-CONICET, Buenos Aires, Argentina.
Departamento de Investigaciones Biomédicas y Biotecnológicas, Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico (CEBBAD), Universidad Maimónides, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Maximiliano Miglio Rodriguez (M)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Mauricio Guzman (M)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Jorge R Geffner (JR)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Jeremías Galletti (J)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Carolina Jancic (C)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.

Marisa I Gómez (MI)

Departamento de Investigaciones Biomédicas y Biotecnológicas, Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico (CEBBAD), Universidad Maimónides, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Analía S Trevani (AS)

Laboratorio de Inmunidad Innata, Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH